Agreement of expert judgment in causality assessment of adverse drug reactions

被引:60
作者
Arimone, Y [1 ]
Bégaud, B
Miremont-Salamé, G
Fourrier-Réglat, A
Moore, N
Molimard, M
Haramburu, F
机构
[1] INSERM, U657, F-33076 Bordeaux, France
[2] Univ Bordeaux 2, Dept Pharmacol, F-33076 Bordeaux, France
关键词
pharmacovigilance; causality; judgment;
D O I
10.1007/s00228-004-0869-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Global introspection is, with operational algorithms and Bayes' theorem, one of the three main approaches used to assess the causal relationship between a drug treatment and the occurrence of an adverse event. Objective: To analyze and compare the judgments of five senior experts using global introspection about drug causation on a random set of putative adverse drug reactions. Methods: A random sample of 150 drug-effect pairs was constituted. For each pair, five senior experts had to independently assess the probability of drug causation from 0 to 1 by using a 100 mm visual analog scale ( VAS). For analysis, those probabilities were secondarily split into seven levels of causality: excluded ( 0 - 0.05); unlikely (0.06 - 0.25); doubtful (0.26 - 0.45); unassessable/ unclassifiable (0.46 - 0.55); plausible (0.56 - 0.75); likely ( 0.75 - 0.95); and certain ( 0.95 - 1). Agreement among the five experts was assessed using kappa coefficients ( kappa). Results: The overall agreement between experts was poor (kappa = 0.20), although significantly different from chance, and varied according to the level of causality. It was lower for the unlikely, doubtful, unassessable/ unclassifiable, and plausible categories (kappa = 0.03, 0.03, - 0.01, and 0.13, respectively) than for VAS extremes: excluded, likely, and certain ( kappa = 0.40, 0.32, and 0.30, respectively). Conclusion: This study confirms that experts express marked disagreements when assessing drug causality independently. The agreement rate was lower for intermediate levels of causality, especially when strong evidence was lacking for confirming or ruling out drug causality. Therefore, in a decision-making context, a step-by-step consensual approach such as the Delphi method seems necessary to make the assessment of such cases more reliable.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 23 条
[1]  
AURICHE M, 1985, THERAPIE, V40, P301
[2]  
Begaud B., 2000, Dictionary of Pharmacoepidemiology
[3]  
BLANC S, 1979, CLIN PHARMACOL THER, V25, P493
[4]  
FEINSTEIN AR, 1974, CLIN PHARMACOL THER, V16, P846
[5]   Delphi as a method to establish consensus for diagnostic criteria [J].
Graham, B ;
Regehr, G ;
Wright, JG .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (12) :1150-1156
[6]  
HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8
[7]   REASONS FOR DISAGREEMENT IN THE STANDARDIZED ASSESSMENT OF SUSPECTED ADVERSE DRUG-REACTIONS [J].
HUTCHINSON, TA ;
FLEGEL, KM ;
HOPINGKONG, H ;
BLOOM, WS ;
KRAMER, MS ;
TRUMMER, EG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (04) :421-426
[8]   ASSESSING METHODS FOR CAUSALITY ASSESSMENT OF SUSPECTED ADVERSE DRUG-REACTIONS [J].
HUTCHINSON, TA ;
LANE, DA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (01) :5-16
[9]  
KARCH FE, 1976, CLIN PHARMACOL THER, V19, P489
[10]   AMBIGUITY OF ADVERSE DRUG-REACTIONS [J].
KOCHWESER, J ;
SELLERS, EM ;
ZACEST, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (02) :75-78